NIH 3T3 fibroblasts were stably transfected with rat brain inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) 3-kinase to explore the relationship between increased production of Ins(1,3,4,5)P4 and the formation of InsP5 and InsP6. Mass measurements of InsP5 and InsP6 revealed no significant difference between kinase-and vector-transfected fibroblasts. 3-kinase-transfected cells grew less rapidly than vector-transfected controls, we determined whether the synthesis of InsP5 and InsP6 was related to a specific phase of the cell cycle.
INTRODUCTION
The agonist-induced formation of inositol 1,4,5-trisphosphate (Ins(1,4,5)P3 )1 from phosphatidylinositol bisphosphate is one of the most ubiquitous signal transduction mechanisms that is activated when cells are exposed to numerous hormones, neurotransmitters, and growth factors (Berridge and Irvine, 1989 of Ins(1,4,5)P3 to its intracellular receptors releases stored Ca2" and leads to elevation of the cytoplasmic Ca2+ concentration ([Ca2+] 1); this Ca2+ signal is one of the key factors initiating cellular responses such as contraction, secretion, and proliferation (Abdel-Latif, 1986 ).
The second messenger, Ins(1,4,5)P3, is rapidly metabolized to form numerous inositol phosphate isomers and derivatives. The complexity of this process is increased by the phosphorylation of Ins(1,4,5)P3 to Ins (1, 3, 4, 5) P4 by a specific 3-kinase, followed by dephosphorylation to produce derivatives containing phosphate at the 3-position (Shears, 1991) . In addition, highly phosphor-ylated myo-inositols such as IP5 and IP6 are present in avian and mammalian cells, as well as in lower organisms (Johnson and Tate, 1969; Heslop et al., 1985; Stephens et al., 1988a; Stephens and Irvine, 1990) . The physiological role of these compounds in cell regulation and their metabolic relationships to Ins(1,4,5) P3 are not yet understood. A metabolic pathway through which Ins(1,4,5)P3 can be converted to Ins (1, 3, 4, 5, 6 )P5, the most abundant InsP5 of mammalian cells (McConnell et al., 1991; Stephens et al., 1991) , has been identified with a sequence of Ins(1,4,5)P3 -* Ins(1,3,4,5)P4 -* Ins(1,3,4)P3 -* Ins(1,3,4,6)P4 -* Ins(1,3,4,5,6)P5 (Balla et al., 1987; Shears et al., 1987) . Several cell types have been found to contain two additional InsP4 isomers, Dand L-Ins(1,4,5,6)P4, both of which have been suggested to be formed from Ins (1, 3, 4, 5, 6 )P5 (Balla et al., 1989b; Menniti et al., 1990; Mattingly et al., 1991) . Also, LIns(1,4,5,6)P4 (=D-Ins(3,4,5,6)P4) has been shown to be a precursor of InsP5 (Stephens et al., 1988b; Balla et al., 1989b; Stephens and Downes, 1990) . In Dictyostelium Ins(3)P can be converted to InsP6 through a sequential phosphorylation cascade (Stephens and Irvine, 1990) , but similar data are not available for mammalian cells.
Recently, v-src-transformed rat-1 fibroblasts were found to possess high Ins(1,4,5)P3 3-kinase activity and to contain a large amount of Ins(1,4,5,6)P4 (ohnson et al., 1989; Mattingly et al., 1991) . In the same cells, Ins(1,4,5)P3 can be converted to Ins (1, 3, 4, 5, 6 )P5 and then dephosphorylated to Ins(1,4,5,6)P4 in the same sequence described above, i.e., Ins(1,4,5)P3 Ins(1,3,4,5)P4 -* Ins(1,3,4)P3 -* Ins(1,3,4,6)P4 Ins(1,3,4,5,6)P5 -* Ins(1,4,5,6)P4 (Mattingly et al., 1991) .
On this basis, the enhanced formation of Ins(1,3,4,5)P4 by the Ins(1,4,5)P3 3-kinase was proposed to result in the accumulation of highly phosphorylated inositols, mainly Ins(1,4,5,6)P4 (Mattingly et al., 1991) .
In the present study, we employed fibroblasts stably transfected with Ins(1,4,5)P3 3-kinase to analyze the relationship of the highly phosphorylated inositols to the second messenger, Ins(1,4,5)P3, and the effects of its increased phosphorylation on the levels of InsP5 and InsP6. MATERIALS AND METHODS Materials [3H]myo-inositol (97 Ci/mmol) and [methyl-3H] thymidine (5 Ci/mmol) were purchased from Amersham (Chicago, IL). Platelet-derived growth factor (PDGF) (human recombinant, BB homodimer) was from Bachem (Torrance, CA). Inositol dehydrogenase (purified), resazurin, diaphorase, and phytase (from Aspergillus ficuum) were obtained from Sigma (St. Louis, MO). NAD was from Fluka (Buchs, Switzerland). Culture media were from Biofluids (Rockville, MD). All other materials and chemicals were of analytical grade.
Transfection of Fibroblasts with the Rat Brain InsP3 3-Kinase
The transfection protocol has already been described previously (Balla et al., 1991) . Briefly, rat brain InsP3 3-kinase cDNA was digested with EcoRI (after removal of an internal Not I restriction site) and ligated with the EcoRI restricted pSP72-Not 2 plasmid (2.4 kilobase [kb] ) (Promega, Madison, WI) that has an EcoRI site between two Not I sites. The resulting pSP72-InsP3-kinase cDNA was digested with Not I and subcloned into the Not I-digested pZIP-neo mammalian expression vector that is under the control of the long terminal repeats of the Moloney murine leukemia virus (Cepko et al., 1984) . The resulting pZIP-neo-InsP3-kinase cDNA was used to transfect NIH 3T3 and CCL39 cells (American Type Culture Collection, Rockville, MD). NIH 3T3 fibroblasts were transfected with the constructed plasmid by the calcium phosphate precipitation method, whereas lipofectin was used to transfect CCL39 cells. Control cells were simultaneously transfected with the pZIP-neo vector lacking the cDNA sequence for the 3-kinase enzyme. Cells were then cultured in selection medium containing G418, and antibiotic-resistant clones were selected 2-3 wk later and assessed for InsP3-kinase expression by immunoblotting.
Measurement of 13HI-labeled Inositol Phosphates in [31HInositol-labeled Fibroblasts
Fibroblasts were plated at a density of 5 X 104 cells/ml on four-well plates (13 mm diameter, Nunc, Kamstrup, Denmark) and cultured for 24 h in Dulbecco's modified Eagle's medium (DMEM) (or McCoy's Medium for CCL39 cells) containing 10% fetal bovine serum (FBS).
Cells were then labeled with [3H] inositol by incubation for 48 h in the respective, inositol-free medium containing 20 gCi/ml [3H]inositol and 0.5% FBS. After two washes, cells were preincubated for 20 min at 37°C and then stimulated with the agonists for selected times. For long-term experiments, cells were labeled for 72 h and stimulated for selected periods by adding PDGF (30 ng/ml) for the indicated times before the end of the labeling period. Cells were washed twice on ice with inositol-free DMEM, and reactions were terminated with icecold perchloric acid (5% final). Inositol phosphates were extracted as described earlier and analyzed by HPLC using a SynChropak Q100 SAX column (Thompson Instruments, Springfield, VA) with elution by a gradient of ammonium phosphate (0.02 M/ min, pH 3.4). Radioactive peaks were identified by coelution with [3HI-labeled inositol phosphate standards and were also compared to [3HI-labeled adrenal glomerulosa cell extracts in which all the major inositol phosphate isomers had been structurally characterized (Balla et al., 1989b) . Protein measurements were made on unlabeled cells cultured under identical conditions using the Bradford method (Bradford, 1976 ) and bovine serum albumin (BSA) as standard.
Measurement of InsP5 and InsP6 Mass
InsP5 and InsP6 mass was determined by measuring the inositol content of purified and dephosphorylated InsP5 and InsP6 from fibroblast extracts by a modification of the method of Maslanski and Busa (1990) . Fibroblasts, grown on 10-cm-diameter culture dishes until 80-90% confluence, were washed twice with Dulbecco's phosphate-buffered saline, and inositol phosphates were extracted after precipitation with perchloric acid (5% final) as described above.
[3H]InsP6 (6-7 pmol/ sample) was then added as an internal standard, and after neutralizing the samples, InsP5 and InsP6 were separated on Sep-Pak Plus mini cartridges (Waters, Milford, MA) by eluting with a gradient of freshly prepared 2 M triethylamine-bicarbonate (Maslanski and Busa, 1990) as shown in Figure 2A . Fractions containing InsP5 and InsP6 were collected and lyophylized. Samples were then dissolved in 0.5 ml of water, and phytase enzyme from Aspergillus ficuum (0.33 U/ml) was added in 0.5 ml glycine buffer (50 mM, pH 2.5) and incubated for 5 h at room temperature. Samples were then applied to minicolumns containing 0.6 ml Amberlite resin (Sigma) and vortexed for 1 min. The eluant was collected in Eppendorf tubes (Sarstedt, Newton, NC) and the samples were washed with 0.5 ml deionized water. Samples were then evaporated in a Speed-Vac centrifuge (Savant, Farmingdale, NY) and dissolved in the buffer used for inositol assays. Inositol was measured with a combined enzymatic assay utilizing the enzyme inositol dehydrogenase and NAD to produce NADH+, which in turn was measured by the use of diaphorase and resazurin to produce the fluorescent compound resorufin (Maslanski and Busa, 1990 phosphate buffer, 0.05% BSA) were added to each tube, followed by 5 Al of resazurin purified by thin-layer chromatography (Maslanski and Busa, 1990 ) usually on the day of the assay and dissolved in 1 M phosphate buffer (pH 6.5) to give concentrations of 40-60 MM. Reactions were started by the addition of 5 Mul of inositol dehydrogenase (2.5 U/ml in 10 mM phosphate buffer pH 6.8, containing 0.05% BSA), and incubations continued for 1 h at 37°C in the dark. At this point 1.0 ml of 0.1 M Tris (pH 9.0) was added, and the fluorescence of the samples was read in a Perkin Elmer (Norwalk, CT) fluorescence spectrophotometer at excitation of 565 nm (slit 5 nm) and emission of 585 nm (5-nm slit). This assay was sensitive enough to detect 5 pmol of inositol and was linear <400 pmol. Because of the purification step, the use of hexokinase (Maslanski and Busa, 1990) was not necessary to remove glucose. In a series of samples, the inositol content was the same whether or not the hexokinase step was included in the procedure. The recovery of InsP6 varied between 15 and 45% depending on the amount of InsP6; the major loss occurred when samples were dissolved after the lyophylization step, in spite of the addition of mannitol, which did not interfere in the inositol assay. In two accuracy experiments, known amounts of InsP6 were run through the procedure and their mass determined and corrected for recovery ( Figure 2C ). (72 h). PDGF (30 ng/ml) was added at selected times before the end of this 72 h "pseudo-labeling" period, when the medium was changed to 0.5 ml of the same medium containing 2-4 ACi/ml [methyl- 3H]thymidine, and incubations were continued for 1 h at 37°C. After 2 washes with ice-cold medium, cells were harvested with 0.5 M NaOH/0. 1% sodium dodecyl sulfate and counted for 3H-activity using Hydrofluor (National Diagnostics, Manville, NJ). For comparison of cell growth rates, vector-and Ins(1,4,5)P3 3-kinase-transfected cells were seeded at the same density on four-well plates and cultured in the presence of 10% FBS. At the times indicated, cell numbers were counted after releasing cells with trypsin-EDTA solution (GIBCO, Grand Island, NY) . In parallel plates, [methyl-3H]thymidine incorporation was measured during a 2-h incubation in serum-free medium containing [methyl-3H]thymidine (2 MCi/ml). (Balla et al., 1991) . The clones used in these studies were also analyzed for PDGF receptor expression and phospholipase-Cy content by 125I-PDGF binding and Western-blot analysis, respectively, to rule out major differences between the signal-transduction pathways of the selected clones (Balla et al., 1991) .
RESULTS

Effects
NIH 3T3 fibroblasts overexpressing Ins(1,4,5)P3 3-kinase showed a characteristic change in the labeling of their inositol-phosphates after incubation for 48 h in the presence of [3H]inositol. Unincorporated inositol levels were significantly higher in kinase-transfected cells, but there was no significant difference in the basal, unstimulated levels of InsP and InsP3 in vector-and Ins(1,4,5)P3 3-kinase-transfected cells. Interestingly, significantly lower labeling of InsP2, InsP5, and InsP6 was consistently observed in kinase-transfected cells compared to vector-transfected controls ( Figure 1 and Table 1 ). The ratios of the amounts from kinase-versus vector-transfected cells calculated for the different inositol phosphates were significantly less than 1.0 and decreased progressively for InsP2, InsP5, and InsP6 (Table 1). A similar difference in the labeling of the higher inositol phosphates was observed in CCL 39 cells transfected with Ins(1,4,5)P3 3-kinase (Balla, unpublished data).
InsP5 and InsP6 Mass Measurements in 3-Kinaseand Vector-transfected Fibroblasts
The lower levels of [3H]-labeled InsP5 and InsP6 in 3-kinase-transfected cells could reflect a difference in their absolute amounts or in their degrees of labeling with [3H]inositol. To resolve this question, mass measurements of InsP5 and InsP6 were performed by a method described for assay of inositol phosphates containing four or less phosphate groups (Maslanski and Busa, 1990) . For the measurement for InsP5 and InsP6, this procedure was modified at several steps. To separate higher inositol phosphates by a method that does not require additional desalting, we utilized Sep-Pak minicolumns and elution with triethylamine-bicarbonate followed by lyophylization. The use of this column with a shallow elution gradient gave a good separation of the major groups of inositol phosphates but not of the individual isomers (Figure 2A ). Fractions containing InsP5 and InsP6, respectively, were collected and lyophylized. For dephosphorylation of the highly phosphorylated inositols, we found that phytase from A. ficuum was more useful than alkaline phosphatase. For the inositol assay, the first reaction (producing scylloInosose and NADH from inositol and NAD+ catalyzed by inositol dehydrogenase) was combined with the second reaction that measured the formation of NADH by the use of diaphorase and resazurin. Although the two reactions have different pH optima, the second is extremely rapid and thus the pH optimum in the coupled reaction was similar to that of the first reaction (Balla, unpublished data Figure 2B . The accuracy of the method was determined by measuring known amounts of InsP6 ( Figure 2C ). When measured by this procedure, the amounts of InsP5 and InsP6 in Ins(1,4,5)P3 3-kinase-transfected and vector-transfected fibroblasts were not significantly different (Table 2) . Agonist-induced Short-term Inositol Phosphate Responses in Fibroblasts Overexpressing Ins(1,4,5)P3 3-Kinase In enzyme-transfected NIH 3T3 cells stimulated with PDGF, the increase in the level of Ins(1,4,5)P3 was greatly diminished and was associated with prominent increases in Ins(1,3,4,5)P4 and Ins(1,3,4)P3 levels. These findings indicated that the Ins(1,4,5)P3 formed upon PDGF stimulation was rapidly converted to Ins(1,3,4,5)P4 by the overexpressed Ins(1,4,5)P3 3-kinase enzyme and then dephosphorylated to Ins(1,3,4)P3. There was also a difference in the kinetics of these changes in that the vector-transfected cells showed a progressive rise to a plateau in inositol phosphate production whereas the enzyme-transfected cells showed a rise followed by a fall, probably reflecting a decrease in phospholipase C activity at later times. This difference might reflect the smaller Ca2" signal elicited by PDGF in these cells (Balla et al., 1991) , secondary to the smaller increases in Ins(1,4,5)P3 and possibly affecting the degree of phospholipase C activity (Figures 1 and 3, top) .
PDGF treatment also increased the production of two additional InsP4 isomers, Ins(1,3,4,6)P4 and D/LIns(1,4,5,6)P4 (the small amount of which did not permit analysis of specific enantiomers). Ins(1,3,4,6) was not detectable at early times of stimulation with our labeling protocol in the Ins(1,4,5)P3 3-kinase-transfected cells, but the increases observed at 5 and 10 min were smaller than in vector-transfected controls. Similarly, the increases in D/L-Ins(1,4,5,6)P4 in response to PDGF were smaller in the kinase-transfected cells. There was no significant change in the level of labeled InsP5 during a 10 min stimulation with PDGF, but its radioactivity in enzyme-transfected cells was only -50% of that observed in vector-transfected controls (Figure 3, bottom) . These changes in the levels and responses of the higher inositol phosphates were not consistent with an increased flow of precursors from Ins(1,4,5)P3, via phosphorylation by the 3-kinase toward the highly phosphorylated inositols.
Growth Rates of Ins(1,4,5)P3 3-Kinase-transfected and Control Cells It was noteworthy during the transfection protocol that the Ins(1,4,5)P3 3-kinase-transfected colonies were more difficult to culture because of their slow growth rates. On the basis of several transfection studies in three different cell lines (NIH 3T3 and CCL 39 fibroblasts and Y-1 adrenocortical tumor cells), the expression of Ins(1,4,5)P3 3-kinase appeared to be inversely related to the growth-rate of the cells (Sim, unpublished data). This difference in growth rate was illustrated by the significantly higher number of vector-transfected cells recovered after 6 d of culture when the same number (0.5 million) of 3-kinase-and vector-transfected cells were seeded (7.3 ± 0.4 and 17.2 ± 1.6 million, respectively; p < 0.0001 SEM, n = 9). Similarly, protein measurements and [3H]thymidine incorporation studies also revealed a difference in the growth rates of the 3-kinase-and vector-transfected cells (Figure 4) . The doubling time of vector-transfected cells was 18.4 ± 2.6 h (SEM, n = 5) compared to 29.8 ± 4.3 h (n = 4) for those trans- As shown in Figure 5 , labeled Ins(1,4,5)P3 levels were rapidly increased by PDGF and were associated with Molecular Biology of the Cell (Weiland et al., 1986; Balla et al., 1987; Shears et al., 1987; Hunyady et al., 1988; Shears, 1989) . Second, the level of InsP5 shows a modest but rapid decrease upon stimulation with Ca2"-mobilizing agonists (Balla et al., 1989a; Menniti et al., 1990) with a concomitant increase in the level of Ins(3,4,5,6)P4 (LIns(1,4,5,6)P4); this finding has led to the suggestion that Ca2"-mobilizing agonists cause breakdown of InsP5 to Ins(3,4,5,6)P4 (Menniti et al., 1990) .
Other data suggest that InsP5 and InsP6, as well as Ins(3,4,5,6)P4, change more profoundly after prolonged exposure to agonists (Balla et al., 1989a) . It has been shown that the conversion of Ins(1,3,4)P3 to Ins(1,3,4,6)P4, the reaction that links InsP5 synthesis to the receptor-mediated formation of Ins(1,4,5)P3, is increased after prolonged agonist stimulation probably via new enzyme synthesis (Balla et al., 1989a) . A dramatic change is observed in the level of higher inositol phosphates in v-src-transformed rat-1 fibroblasts (Mattingly et al., 1991) because of the large, serum-dependent accumulation of an InsP4 isomer, identified as Ins(1,4,5,6)P4, and of InsP5. These transformed cells appear to direct a larger proportion of their Ins(1,4,5)P3 toward polyphosphoinositols, a change that was attributed to their significantly higher Ins(1,4,5)P3 3-kinase activity. On the basis of these findings it was proposed that the increased Ins(1,4,5)P3 3-kinase activity could be responsible for the higher levels of InsP5 and Ins(1,4,5,6)P4 observed in these cells (Mattingly et al., 1991) .
In the present study, NIH 3T3 fibroblasts stably transfected with Ins(1,3,4)P3 3-kinase were used to further investigate this question. The only known source of Ins(1,3,4)P3, a potentially important starting point of InsP5 synthesis, is the Ca2"-mobilizing second messenger Ins(1,4,5)P3 via phosphorylation to Ins(1,3,4,5)P4
by InsP3 3-kinase and dephosphorylation by Ins(1, 4,5)P3/Ins(1,3,4,5)P4 5-phosphatase. For this reason, overexpression of the 3-kinase was expected to increase the availability of this precursor for InsP5 synthesis. However, we did not find increased levels of InsP5 or InsP6, whether assessed by their total mass or radioactivity, in [3H] inositol-labeled cells. The lack of an increase in the amount or labeling of these compounds contrasted with the increased activity of the overexpressed enzyme toward both endogenously formed or exogenously added (to permeabilized cells) Ins(1,4,5)P3 (see also Balla et al., 1991) . In fact, decreased labeling of InsP5 and InsP6 and their potential precursor InsP4 isomers (Ins(1,3,4,6 )P4 and D/L-Ins(1,4,5,6)P4) was observed in enzyme-transfected cells, even though there was no significant change in the labeling of basal InsP and InsP3. The latter finding indicates that the PtdIns pool was probably (as expected) labeled to isotopic equilibrium in both cases.
These data demonstrate that the synthesis of Ins(1,3,4,6)P4 (and therefore InsP5) is not increased by high substrate (Ins(1,3,4) P3) levels. This conclusion was also suggested by the inability of Li' ions to enhance the accumulation of Ins(1,3,4,6)P4 in spite of the greatly enhanced increases in agonist-induced Ins(1,3,4)P3 formation in the presence of this cation . Studies on partially purified Ins(1,3,4)P3 6-kinase have shown that the enzyme is saturated by small elevations of Ins(1,3,4)P3 because of its low Km value (0.3-0.5 ,uM) (Hansen et al., 1988) and that Ins(1,3,4)P3 is largely metabolized by dephosphorylation to Ins(3,4)P2 (Hughes et al., 1989) . These findings raise the possibility that Ins(1,3,4,6)P4 is mainly produced by an alternative mechanism, such as through Ins(1,4,6)P3 as suggested for the avian erythrocyte (Stephens and Downes, 1990) or from InsP5, and hence increases in Ins(1,3,4)P3 would have little (if any) effect on its levels.
A possible explanation for the lower levels of InsP5 and InsP6 labeling in Ins(1,4,5)P3 3-kinase-transfected cells was the slower growth rate of enzyme-transfected cells compared to vector-transfected controls. It is feasible to assume that InsP5 and InsP6 did not reach isotopic equilibrium even after 48-72 h labeling with [3H] inositol and that more rapidly growing cells would label their InsP5/InsP6 pools to higher specific activity (radioactivities were also corrected to protein levels). This, however, also means that at least some of the InsP5/InsP6 synthesis must occur in relation to cell-cycle associated event(s). When changes in labeled inositol phosphate levels in response to PDGF were analyzed in a synchronized cell population, we observed an early transient increase in D/L-Ins(1,4,5,6)P4 levels, peaking at -2.5 h after PDGF addition; the kinetics of the response correlated with phospholipase C activity, the latter being no longer apparent after 5-h stimulation. (Stephens et al., 1988a; Balla et al., 1989b; Stephens and Downes, 1990) or a product of InsP5 hydrolysis (Menniti et al., 1990) . Given (Stephens et al., 1988a; Stephens and Downes, 1990 Very little is known about the function of the highly phosphorylated inositols. They have been reported to have extracellular actions in the central nervous system (Vallejo et al., 1987) , but their only known intracellular function is the modulation of oxygen-binding affinity of haemoglobin in avian erythrocytes (Isaacks and Harkness, 1980) . The present results support the previous proposal (Balla et al., 1989a ) that their function(s) might be related to long-term cellular responses. There are increasing numbers of observations consistent with this idea: inositol penta-and hexakisphosphates are more intensely synthesized in germinating seeds, where they are believed to serve as phosphate reserves (Cosgrove, 1980) ; they show a characteristic increase during oocyte maturation in Xenopus laevis (Ji et al., 1989) ; and they change strikingly during differentiation of promyelocytic HL 60 cells (Michell et al., 1990) . As mentioned earlier, cell transformation also has a marked effect on higher inositol phosphate labeling. It is becoming increasingly evident that the higher inositol phosphates represent a separate system from the inositol lipid-derived inositol phosphates that are involved in Ca2+ signaling. It will be interesting to see if the two systems operate in the same or in separate cellular compartments.
Further studies are needed to decide if the slower growth rate of kinase-transfected cells is specifically related to the overexpression of Ins(1,4,5)P3 3-kinase activity. Nevertheless, if Ins(1,4,5)P3 production and the consequent Ca2+ mobilization are critical signals in driving cells through the cell cycle, it is conceivable that reduction of Ins(1,4,5)P3 levels because of rapid conversion to Ins(1,3,4,5)P4 could affect growth responses in a negative manner. From these results, it is also clear that enhanced InsP3 3-kinase activity is not causally related to the transformed phenotype of v-src-transformed rat-1 fibroblasts. It is an intriguing possibility that the enhanced InsP3 3-kinase activity of the transformed cell could be an adaptation as part of an attempt to retard the high growth rate of the transformed cells.
In summary, overexpression of Ins(1,4,5)P3 3-kinase in stably transfected NIH 3T3 cells does not cause enhanced [3H]inositol labeling or an increase in the amounts of the highly phosphorylated inositols. On the contrary, the labeling of these compounds is reduced in enzyme-transfected cells compared to vector-transfected controls. The lower rates of production of the highly phosphorylated inositols appears to be related to the slower growth rate of the enzyme-transfected cells. This assumption is supported by the PDGF-induced changes in the levels of higher inositol phosphates in synchronized fibroblasts. Changes in [3H]inositol-labeled InsP5 and InsP6 occurred only at later stages of hormone stimulation, and the more rapid changes in [3H]Ins(1,3,4,6)P4 and D/L-Ins(1,4,5,6)P4 were dependent on the labeling state of the InsP5/InsP6 pools rather than the agonist-induced increase of Ins(1,3,4)P3 or the activity of the InsP3 3-kinase pathway. The temporal pattern of the growth factor-induced changes in higher inositol phosphates is consistent with their involvement in growth-related cellular responses and the slower growth rate of Ins(1,4,5)P3 3-kinasetransfected cells suggests that the inositol tris/tetrakisphosphate pathway is involved in control of the cell cycle.
